NYSE$UHS

Universal Health Services Inc · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

Reported net income attributable to UHS was $258.7 million, or $3.80 per diluted share.

Universal Health Services, Inc. reported strong Q3 2024 results, with net revenues increasing by 11.2% to $3.963 billion and net income attributable to UHS reaching $258.7 million, or $3.80 per diluted share, compared to $167.0 million, or $2.40 per diluted share, in Q3 2023. Adjusted net income was $252.5 million, or $3.71 per diluted share. EBITDA net of NCI was $528.6 million, representing 13.3% of net revenues.

  • Net revenues increased by 11.2% to $3.963 billion compared to Q3 2023.
  • Net income attributable to UHS was $258.7 million, or $3.80 per diluted share.
  • Adjusted net income attributable to UHS was $252.5 million, or $3.71 per diluted share.
  • EBITDA net of NCI was $528.6 million, or 13.3% of net revenues.

Headline financials

Total Revenue

$3.96B

Previous: $3.56B+11.2%
EPS

$3.80

Previous: $2.55+49.0%
Avg Licensed Beds

6.8K

Previous: 6.7K+1.9%
Avg Available Beds

6.6K

Previous: 6.5K+2.0%
Patient Days

401.5K

Previous: 384.3K+4.5%
Avg Daily Census

4.4K

Previous: 4.2K+4.5%
Occupancy Licensed Beds

64.2%

Previous: 62.7%+2.4%
Occupancy Available Beds

65.9%

Previous: 64.3%+2.5%
Admissions

83.1K

Previous: 80.1K+3.8%
Length of Stay

4.8

Previous: 4.8+0.0%
BH Avg Licensed Beds

24.3K

Previous: 24.2K+0.5%
BH Avg Available Beds

24.2K

Previous: 24.1K+0.5%
BH Patient Days

1.6M

Previous: 1.6M+1.4%
BH Avg Daily Census

17.6K

Previous: 17.4K+1.4%
BH Occupancy Licensed

72.6%

Previous: 71.9%+1.0%
BH Occupancy Available

72.9%

Previous: 72.2%+1.0%
BH Admissions

120.0K

Previous: 118.5K+1.3%
BH Length of Stay

13.5

Previous: 13.5+0.0%
Capital Expenditures

-$698M

Previous: -$537M-30.0%
Free Cash Flow

-$439M

Previous: -$370M-18.8%
Net Income

$259M

Previous: $167M+54.9%
Operating Income

$384M

Previous: $285M+34.6%
Cash & Equivalents

$106M

Previous: $80.8M+31.3%
Total Assets

$14.4B

Previous: $13.9B+3.5%
Stock-Based Comp

$26.6M

Previous: $22.6M+17.3%

Revenue & EPS history

UHS · Revenue · Quarterly

$3.96B

Q3 2024+11.2%vs Q3 2023
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Revenue by segment

UHS · $3.56B total across 2 segments · Q3 2023

  • Acute Care Services
    $2.02B+5.1%
  • Behavioral Health Services
    $1.54B+7.5%

Forward guidance

UHS did not provide forward guidance in the Q3 2024 earnings report.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

+0.3%

Avg return

Earnings day

+0.3%

Avg return

5 days after

+0.7%

Avg return

30 days after

49%

34 / 69 earnings

Positive

+17.5%

Q3 2022

Best reaction

-13.4%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-9.5%-7.0%-16.4%
Q4 2025-5.5%-1.0%-9.9%
Q3 2025+2.5%+1.4%+14.1%
Q2 2025-0.2%+3.3%+7.3%
Q1 2025-0.6%+3.4%+10.5%
Q4 2024+3.3%-3.8%+3.4%
Q3 2024-13.4%-12.1%-15.5%
Q2 2024+10.6%+17.3%+25.8%
Q1 2024+0.1%+2.6%+6.9%
Q4 2023-1.6%+4.1%+11.0%
Q3 2023-0.2%-0.6%+11.4%
Q2 2023-4.6%-6.5%-12.3%
Q1 2023+1.5%+6.9%-9.3%
Q4 2022-9.1%-13.5%-15.5%
Q3 2022+17.5%+25.8%+39.3%
Q2 2022-1.5%+1.3%-5.7%
Q1 2022-5.7%-7.8%-8.1%
Q4 2021+8.6%+8.7%+11.1%
Q3 2021-7.0%-8.5%-5.0%
Q2 2021+4.2%+5.1%+1.6%
Q1 2021+0.3%+2.0%+10.1%
Q4 2020-9.1%-6.2%-2.0%
Q3 2020+3.0%+11.1%+24.2%
Q2 2020+0.9%+1.7%+0.2%
Q1 2020+3.7%-2.5%+8.6%
Q4 2019-5.3%-2.7%-34.3%
Q3 2019-4.6%-4.0%-3.6%
Q2 2019+10.9%+11.6%+4.7%
Q1 2019-0.8%-2.6%-5.5%
Q4 2018+3.9%+2.7%+0.1%
Q3 2018-5.3%-1.0%+8.0%
Q2 2018+9.3%+9.3%+12.0%
Q1 2018-4.6%-5.2%-3.2%
Q4 2017-1.3%+5.3%+0.7%
Q3 2017-6.9%-8.3%-9.9%
Q2 2017-9.2%-10.3%-12.6%
Q1 2017-2.0%-0.1%-3.0%
Q4 2016-0.9%-0.8%-0.8%
Q3 2016+0.6%-0.7%+1.3%
Q2 2016-4.4%-5.2%-12.1%
Q1 2016+2.1%
Q4 2015+2.4%
Q3 2015+2.4%
Q2 2015+2.1%
Q1 2015-0.7%
Q4 2014+3.8%
Q3 2014-1.0%
Q2 2014+6.8%
Q1 2014+8.3%
Q4 2013-2.6%
Q3 2013+2.6%
Q2 2013+3.3%
Q1 2013+3.3%
Q4 2012-0.0%
Q3 2012-3.2%
Q2 2012+4.8%
Q1 2012-1.7%
Q2 2011+2.0%
Q4 2011+2.0%
Q3 2011+3.8%
Q1 2010+3.8%
Q4 2010+3.8%
Q1 2011+3.8%
Q2 2010+5.0%
Q3 2009+0.0%
Q3 2010+0.0%
Q4 2009-0.3%
Q2 2009-0.3%
Q4 2008-0.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro